Jackson Acquisition Company II (JACS)
Jackson Acquisition Company II (NYSE: JACS) is a common stock listing of a company with no significant operating business of its own. Incorporated in 2024 and based in Alpharetta, Georgia, it is structured to pursue a future business combination, such as a merger, share exchange, asset acquisition, share purchase, recapitalization, or reorganization, with one or more businesses or entities in the healthcare industry. As a listed company in the Financials sector and Capital Markets industry, its current profile is centered on identifying and completing a transaction rather than on ongoing commercial operations.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-JACS
|
$6.98
|
-34.8% Downside
|
Overvalued
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 13, 2026
|
35.7x
|
6,033.3x
|
—
|
316.6 M
|
316.4 M
|
0.1%
|
66.1%
|
0.8
|
—
|
-4.1%
|
